Skip to main content
Premium Trial:

Request an Annual Quote

Erin Carlson: Bacterial Perception


Recommended by: David Clemmer, Indiana University

Indiana University's Erin Carlson aims to look at the environment with a bacterium's perception. She is working on developing new chemical techniques to study bacterial pathogenesis, with the main goal of developing new proteomic techniques to examine two-component signaling in bacteria — the mechanism by which they sense the environment around them. "The goal is to create techniques to study bacterial signaling and potentially utilize the proteins we study as new therapeutic targets," Carlson says. "My lab is also very interested in the exploration of natural products, which are produced in nature as potential molecules that could act as those therapeutic agents."

Carlson became interested in studying infectious diseases during her travels around the world. "I've seen a lot of these types of infectious disease, and I felt that it was something I was interested in working on, especially diseases that don't receive a lot of attention in the United States, such as tuberculosis," she says.

But the pursuit of her interest isn't easy. "Since we use a whole facet of interdisciplinary tools, it can be very difficult to pursue studies. So my students have to be experts in organic chemistry, analytical chemistry, biochemistry, microbiology, and being able to take all of those techniques together and efficiently utilize them can be a challenge," Carlson adds.

Looking ahead

In the coming years, Carlson hopes to have developed tools to explore bacteria, discover compounds that can treat drug-resistant infections, and present new avenues of treatment that don't cause the creation of new resistant organisms as readily.

And the Nobel goes to...

If she gets a call from Stockholm, Carlson hopes it would be for having developed "a facile method to create vaccines for basically any infectious disease," she says.

Filed under

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.